[
  {
    "abbr": "abbr",
    "description": "description"
  },
  {
    "abbr": "2-h PG",
    "description": "2-h plasma glucose"
  },
  {
    "abbr": "ACCORD-MIND",
    "description": "Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes"
  },
  {
    "abbr": "ACIP",
    "description": "Advisory Committee on Immunization Practices"
  },
  {
    "abbr": "ACOG",
    "description": "American College of Obstetricians and Gynecologists"
  },
  {
    "abbr": "AD",
    "description": "Autosomal dominant"
  },
  {
    "abbr": "ADA",
    "description": "American Diabetes Association"
  },
  {
    "abbr": "AHEAD",
    "description": "Action For Health in Diabetes"
  },
  {
    "abbr": "AIDS",
    "description": "Acquired immunodeficiency syndrome"
  },
  {
    "abbr": "AR",
    "description": "Autosomal recessive"
  },
  {
    "abbr": "ARB",
    "description": "Angiotensin receptor blocker"
  },
  {
    "abbr": "ARV",
    "description": "Antiretroviral"
  },
  {
    "abbr": "ASCVD",
    "description": "Atherosclerotic cardiovascular disease"
  },
  {
    "abbr": "BMD",
    "description": "Bone mineral density"
  },
  {
    "abbr": "BMI",
    "description": "Body mass index"
  },
  {
    "abbr": "BRFSS",
    "description": "The Behavioral Risk Factor Surveillance System"
  },
  {
    "abbr": "CCM",
    "description": "Chronic care model"
  },
  {
    "abbr": "CDC",
    "description": "Centers for Disease Control and Prevention"
  },
  {
    "abbr": "CFRD",
    "description": "Cystic fibrosis related diabetes"
  },
  {
    "abbr": "CGM",
    "description": "Continuous glucose monitoring"
  },
  {
    "abbr": "CHF",
    "description": "Congestive heart failure"
  },
  {
    "abbr": "CHW",
    "description": "Community health worker"
  },
  {
    "abbr": "CHWs",
    "description": "Community health workers"
  },
  {
    "abbr": "CKD",
    "description": "Chronic kidney disease"
  },
  {
    "abbr": "CVD",
    "description": "Cardiovascular disease"
  },
  {
    "abbr": "CVOT",
    "description": "Cardiovascular outcomes trial"
  },
  {
    "abbr": "DCCT",
    "description": "Diabetes Control and Complications Trial"
  },
  {
    "abbr": "DKA",
    "description": "Diabetic ketoacidosis"
  },
  {
    "abbr": "DM",
    "description": "Diabetes mellitus"
  },
  {
    "abbr": "DPP",
    "description": "Diabetes Prevention Program"
  },
  {
    "abbr": "DSMES",
    "description": "Diabetes self-management education and support"
  },
  {
    "abbr": "eGFR",
    "description": "Estimated glomerular filtration rate"
  },
  {
    "abbr": "FDA",
    "description": "Food and Drug Administration"
  },
  {
    "abbr": "FI",
    "description": "Food insecurity"
  },
  {
    "abbr": "FPG",
    "description": "Fasting plasma glucose"
  },
  {
    "abbr": "FRAX",
    "description": "Fracture risk assessment tool"
  },
  {
    "abbr": "GDM",
    "description": "Gestational diabetes mellitus"
  },
  {
    "abbr": "GLT",
    "description": "Glucose load test"
  },
  {
    "abbr": "HAPO",
    "description": "Hyperglycemia and Adverse Pregnancy Outcome"
  },
  {
    "abbr": "HDL",
    "description": "High-density lipoprotein"
  },
  {
    "abbr": "HIV",
    "description": "Human immunodeficiency virus"
  },
  {
    "abbr": "HOMA",
    "description": "Homeostatic model assessment"
  },
  {
    "abbr": "IADPSG",
    "description": "International Association of the Diabetes and Pregnancy Study Groups"
  },
  {
    "abbr": "IFG",
    "description": "Impaired fasting glucose"
  },
  {
    "abbr": "IGT",
    "description": "Impaired glucose tolerance"
  },
  {
    "abbr": "INS",
    "description": "Insulin gene"
  },
  {
    "abbr": "IPEX",
    "description": "Immunodysregulation, polyendocrinopathy, enteropathy X-linked"
  },
  {
    "abbr": "IUGR",
    "description": "Intrauterine growth restriction"
  },
  {
    "abbr": "LDL",
    "description": "Low-density lipoprotein"
  },
  {
    "abbr": "MACE",
    "description": "Major adverse cardiac event"
  },
  {
    "abbr": "MNT",
    "description": "Medical nutrition therapy"
  },
  {
    "abbr": "MODY",
    "description": "Maturity-onset diabetes of the young"
  },
  {
    "abbr": "NADAC",
    "description": "National Average Drug Acquisition Cost"
  },
  {
    "abbr": "NDDG",
    "description": "National Diabetes Data Group"
  },
  {
    "abbr": "NGSP",
    "description": "National Glycohemoglobin Standardization Program"
  },
  {
    "abbr": "NHANES",
    "description": "National Health and Nutrition Examination Survey"
  },
  {
    "abbr": "NHIS",
    "description": "National Health Interview Survey"
  },
  {
    "abbr": "NIH",
    "description": "National Institutes of Health"
  },
  {
    "abbr": "NODAT",
    "description": "New-onset diabetes after transplantation"
  },
  {
    "abbr": "NRTIs",
    "description": "Nucleoside reverse transcriptase inhibitors"
  },
  {
    "abbr": "OGTT",
    "description": "Oral glucose tolerance test"
  },
  {
    "abbr": "PAD",
    "description": "Peripheral arterial disease"
  },
  {
    "abbr": "Pis",
    "description": "Protease inhibitors"
  },
  {
    "abbr": "PPC",
    "description": "Professional Practice Committee"
  },
  {
    "abbr": "PPSV23",
    "description": "23-valent pneumococcal polysaccharide vaccine"
  },
  {
    "abbr": "PTDM",
    "description": "Posttransplantation diabetes mellitus"
  },
  {
    "abbr": "RCAD",
    "description": "Renal cysts and diabetes"
  },
  {
    "abbr": "UL",
    "description": "Upper limit"
  },
  {
    "abbr": "WHO",
    "description": "World Health Organization"
  },
  {
    "abbr": "DD",
    "description": "Diabetes distress"
  },
  {
    "abbr": "DPPOS",
    "description": "Diabetes Prevention Program Outcomes Study"
  },
  {
    "abbr": "DASH",
    "description": "Dietary Approaches to Stop Hypertension"
  },
  {
    "abbr": "ALA",
    "description": "Alpha-linolenic acid"
  },
  {
    "abbr": "EPA",
    "description": "Eicosapentaenoic acid"
  },
  {
    "abbr": "DHA",
    "description": "Docosahexaenoic acid"
  },
  {
    "abbr": "DPS",
    "description": "Diabetes Prevention Study"
  },
  {
    "abbr": "CMS",
    "description": "Centers for Medicare and Medicaid Services"
  },
  {
    "abbr": "DPRP",
    "description": "Diabetes Prevention Recognition Program"
  },
  {
    "abbr": "GLP",
    "description": "Glucagon-like peptide"
  },
  {
    "abbr": "VADT",
    "description": "Veterans Affairs Diabetes Trial"
  },
  {
    "abbr": "ADAG",
    "description": "International A1C Derived Average Glucose"
  },
  {
    "abbr": "UKPDS",
    "description": "UK Prospective Diabetes Study"
  },
  {
    "abbr": "EDIC",
    "description": "Epidemiology of Diabetes Interventions and Complications"
  },
  {
    "abbr": "MI",
    "description": "Myocardial infarction"
  },
  {
    "abbr": "RYGB",
    "description": "Roux-en-Y gastric bypass"
  },
  {
    "abbr": "GI",
    "description": "Gastrointestinal"
  },
  {
    "abbr": "FBG",
    "description": "Fasting blood glucose"
  },
  {
    "abbr": "CSII",
    "description": "Continuous subcutaneous insulin infusion"
  },
  {
    "abbr": "DKD",
    "description": "Diabetic kidney disease"
  },
  {
    "abbr": "IR",
    "description": "Immediate release"
  },
  {
    "abbr": "ER",
    "description": "Extended release"
  },
  {
    "abbr": "GIP",
    "description": "Glucose-dependent insulinotropic peptide"
  },
  {
    "abbr": "GRADE",
    "description": "Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study"
  },
  {
    "abbr": "JDRF",
    "description": "Juvenile Diabetes Research Foundation"
  },
  {
    "abbr": "eGFR",
    "description": "Estimated glomerular filtration rate"
  },
  {
    "abbr": "AWP",
    "description": "Average wholesale prices"
  },
  {
    "abbr": "SQ",
    "description": "Subcutaneous"
  },
  {
    "abbr": "NASH",
    "description": "Nonalcoholic steatohepatitis"
  },
  {
    "abbr": "XL",
    "description": "Extended release"
  },
  {
    "abbr": "FEV-1",
    "description": "Forced expiratory volume in one second"
  },
  {
    "abbr": "SGLT2",
    "description": "Sodium glucose cotransporter 2"
  },
  {
    "abbr": "ELIXA",
    "description": "Evaluation of Lixisenatide in Acute Coronary Syndrome"
  },
  {
    "abbr": "HR",
    "description": "Hazard ratio"
  },
  {
    "abbr": "LEADER",
    "description": "The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsdA Long Term Evaluation"
  },
  {
    "abbr": "TECOS",
    "description": "Trial Evaluating Cardiovascular Outcomes with Sitagliptin"
  },
  {
    "abbr": "EXSCEL",
    "description": "Exenatide Study of Cardiovascular Event Lowering"
  },
  {
    "abbr": "LIPID",
    "description": "The Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus"
  },
  {
    "abbr": "AIM-HIGH",
    "description": "The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes"
  },
  {
    "abbr": "IMPROVE-IT",
    "description": "The IMProved Reduction of Outcomes: Vytorin Efficacy International Trial"
  },
  {
    "abbr": "HOT",
    "description": "Hypertension optimal treatment"
  },
  {
    "abbr": "PCSK",
    "description": "Randomized Evaluation of the Effects of Anacetrapib Through Lipid-modification"
  },
  {
    "abbr": "EMPA-REG",
    "description": "(Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients"
  },
  {
    "abbr": "RR",
    "description": "Relative risk"
  },
  {
    "abbr": "CETP",
    "description": "Cholesteryl ester transfer protein"
  },
  {
    "abbr": "BI",
    "description": "Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk"
  },
  {
    "abbr": "HPS",
    "description": "Heart Protection Study"
  },
  {
    "abbr": "BP",
    "description": "Blood pressure"
  },
  {
    "abbr": "CANVAS",
    "description": "Canagliflozin Cardiovascular Assessment Study"
  },
  {
    "abbr": "GE",
    "description": "Urinary albumin to creatinine ratio"
  },
  {
    "abbr": "ST",
    "description": "Acute kidney injury"
  },
  {
    "abbr": "ACE",
    "description": "Angiotensin converting enzyme"
  },
  {
    "abbr": "ECG",
    "description": "Electrocardiogram"
  },
  {
    "abbr": "HPS2-THRIVE",
    "description": "Heart Protection Study 2 Treatment of HDL to Reduce the Incidence of Vascular Events"
  },
  {
    "abbr": "REG",
    "description": "Acute coronary syndrome"
  },
  {
    "abbr": "TIMI",
    "description": "Thrombolysis in Myocardial Infarction"
  },
  {
    "abbr": "AGENTS",
    "description": "The Action to Control Cardiovascular Risk in Diabetes blood pressure"
  },
  {
    "abbr": "CHD",
    "description": "Coronary heart disease"
  },
  {
    "abbr": "NPH",
    "description": "Normal pressure hydrocephalus"
  },
  {
    "abbr": "A1C",
    "description": "Glycated hemoglobin"
  },
  {
    "abbr": "IM",
    "description": "Intramuscular"
  },
  {
    "abbr": "SGLT1",
    "description": "Sodium glucose cotransporter 1"
  },
  {
    "abbr": "GLP-1",
    "description": "Glucagon-like peptide 1"
  },
  {
    "abbr": "HF",
    "description": "Heart failure"
  },
  {
    "abbr": "DPP-4",
    "description": "Dipeptidyl peptidase 4 inhibitor"
  }
]